zesperone + serlift
TRANSCRIPT
®
Alex Team Rana EL.Abd
®
© Sun Pharmaceutical Industries Limited. All Rights Reserved. 2
© Sun Pharmaceutical Industries Limited. All Rights Reserved. 3
Products sold in over 150 countries Over 3000 products 45 factories
© Sun Pharmaceutical Industries Limited. All Rights Reserved.
Active Constituent: Risperidone
Concentration : 2 mg – 4 mg
Use : Anti-psychotic
Route of administration : Oral
Dosage form : 10 Scored Tab
Price : 2 mg (30 L.E)
4 mg (45 L.E)
Zesperone®
© Sun Pharmaceutical Industries Limited. All Rights Reserved. 5
Advantages
• More Selective in its action
• Less EPS
• No effect on prolactin
production
Zesperone®
7
FDA approval (Aug 2010)
(Clinical Antipsychotic Trial OF Intervention Effectiveness )
CATIE Study
Body Weight: Change from Baseline
0%10%20%30%40%
Risperidone Olanzapine
Glucose: Change from Baseline
0.0
5.0
10.0
15.0
Risperidone Quitapine Olanzapine
Wei
ght G
ain
>7%
Expo
sure
-Adj
uste
dM
ean
(mg/
dL)
Quitapine
Fasting Triglycerides: Change from Baseline
-20.0-5.010.025.040.0
RisperidoneExpo
sure
-Adj
uste
dM
ean
(mg/
dL)
Olanzapine
© Sun Pharmaceutical Industries Limited. All Rights Reserved.
Active Constituent: Sertraline HCL
Concentration : 100 mg
Uses : Depression - OCD
Route of administration : Oral
Dosage form : Film coated tablets ( 10 Scored Tab )
Dose : 50mg/day ( may increases ) .. Max. 200 mg/day
Price : 40 L.E
© Sun Pharmaceutical Industries Limited. All Rights Reserved. 13
© Sun Pharmaceutical Industries Limited. All Rights Reserved.
1st Choice
Advantages
• More tolerated
• Less sedation
• Safe
• No CVS side effects
• No Atropine like effects
FDA approval (Feb 2007)
Published online January 29, 2009 DOI:10.1016/S0140-6736(09)60046-5Lancet
SSRIs Meta analysis in review
© Sun Pharmaceutical Industries Limited. All Rights Reserved.
SSRIs Meta analysis in review
• 117 randomised trials
• 25,928 participants from 1991 up to Nov 30, 2007 .
• Treatment of unipolar major depression in adults using :
Bupropion, Citalopram, Duloxetine, Escitalopram, Fluoxetine,
Fluvoxamine,Milnacipran, Mirtazapine, Paroxetine, Reboxetine,
Sertraline, and Venlafaxine.
MethodologySSRIs Meta analysis in review
© Sun Pharmaceutical Industries Limited. All Rights Reserved.
SSRIs Meta analysis in review
• Sertraline might be the best choice in depression treatment.
• The most favourable balance between benefit acceptability, and acquisition cost.
Findings
SSRIs Meta analysis in review
© Sun Pharmaceutical Industries Limited. All Rights Reserved. 19
Thank YouRana ELabdTel : +91 22 6645 5645, Ext 000Tel Direct : +91 22 66455645Mobile : [email protected]
Thank You! For more information please contact:
© 2010 Sun Pharmaceutical Industries Limited., All Rights Reserved.“SUN Pharma”, The Sun Pharmaceutical Industries Logo are trademarks of Sun Pharmaceutical Industries Limited.
This material was used during an oral presentation; it is not a complete record of the discussion. This work may not be used, sold, transferred, adapted, abridged, copied or reproduced in whole on or in part in any manner or form or in any media without the prior written consent. All product names and company names and logos mentioned herein are the trademarks or registered trademarks of their respective owners.